BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Pfizer-Backed DEM Bio Launches to Leverage CRISPR in Immuno-Oncology

  DEM BioPharma has $70 million to get started on novel immunotherapeutics to treat cancer following a successful financing round.

  June 23, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  BridgeBio Sees Changes in Key Canavan Disease Markers

  BridgeBio released early data from its Phase I/II CANaspire clinical trial, indicating that BBP-812 might be a promising gene therapy for the ultra-rare Canavan disease.

  June 23, 2022

   · 

  3 min read

   · 

  Tristan Manalac
• 

  Policy

  New Variants Escape Antibody Responses of Vaccinated, Long COVID Affects 1 in 5

  Although COVID-19 appears to be on the run in the U.S., there is still a threat of resurgence. Here’s a look at some of the most recent COVID-19 stories and research.

  June 23, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  Moderna, GSK, Sanofi, AstraZeneca and BioNTech Expand Global Ops

  It’s been a busy month for big biopharma companies looking to expand operations with Moderna, AstraZeneca, Sanofi and more are setting up new facilities internationally.

  June 23, 2022

   · 

  4 min read

   · 

  Vanessa Doctor, RN
• 

  Research Roundup: Single Scan Diagnoses Alzheimer’s, Women Underrepresented in Trials

  Researchers have been able to use machine learning to evaluate MRI scans and diagnose Alzheimer’s in a single scan. For that and more research news, continue reading.

  June 23, 2022

   · 

  5 min read

   · 

  Mark Terry
• 

  Job Trends

  Regeneron Breaks Ground on $1.8B NY Expansion Project

  Regeneron has broken ground on a $1.8 billion expansion of its Tarrytown, NY facilities that will add at least 1,000 new full-time jobs.

  June 23, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Novartis Tops Busy Week with Solid Tumor Combo Drug Approval

  In addition to patent cases, partnerships and pledging money to global tropical disease efforts, Novartis scored a win on a combo-treatment for solid tumors.

  June 23, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Policy

  WHO Mulls Emergency Declaration on Monkeypox, Poliovirus Detected in UK Water Supply

  The WHO will decide whether to declare a public health emergency following the recent outbreaks of monkeypox, and poliovirus has been detected in London water samples.

  June 23, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano, M.S.
• 

  Job Trends

  U.S. House Approves New Federal Biomedical Agency to ‘Make the Impossible Possible’

  In an overwhelming vote of support, the U.S. House of Representatives approved the creation of a new department within the National Institutes of Health that is focused on biomedical innovation.

  June 23, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  AstraZeneca Looks to Add to Small Group of Wilson Disease Drugs With It’s ALXN1840

  An experimental AstraZeneca drug for Wilson disease hit the mark in a Phase III study in which the drug, ALXN1840, was able to mobilize copper three times greater than standard-of-care.

  June 23, 2022

   · 

  3 min read

   · 

  Alex Keown